US Broker Ratings

Arcus Biosciences (RCUS) Stock Analysis: Exploring a 32% Potential Upside Amid Promising Cancer Therapies

Arcus Biosciences, Inc. (NASDAQ: RCUS), a burgeoning player in the biotechnology sector, has captivated investor interest due to its innovative approach to cancer therapy. This Hayward,..

Syndax Pharmaceuticals (SNDX) Stock Analysis: Exploring a 92.59% Potential Upside in the Biotech Sector

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a leading player in the biotechnology sector, is capturing investor attention with its promising portfolio of cancer-focused therapies and an impressive..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Exploring a 24.41% Potential Upside in the Diagnostics Sector

As Fulgent Genetics, Inc. (NASDAQ: FLGT) navigates the competitive landscape of the Diagnostics & Research industry, investors are keenly observing its performance metrics and future potential...

Weave Communications, Inc. (WEAV) Stock Analysis: A 47.54% Potential Upside Beckons Investors

Weave Communications, Inc. (NASDAQ: WEAV) is carving out a niche in the Healthcare sector, specifically within Health Information Services. Headquartered in Lehi, Utah, the company is..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: A Promising 128% Upside in Biotech Innovation

Investors with an appetite for biotechnology stocks may find Gyre Therapeutics, Inc. (NASDAQ: GYRE) an intriguing opportunity, as the company sits at the intersection of innovation..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Exploring the 44% Upside Potential

Praxis Precision Medicines, Inc (NASDAQ: PRAX), a Boston-based biotechnology firm, is gaining traction among investors with its promising pipeline focused on central nervous system (CNS) disorders...

GH Research PLC (GHRS) Stock Analysis: A Promising Biotech with 120% Upside Potential

GH Research PLC (NASDAQ: GHRS), a Dublin-based clinical-stage biopharmaceutical firm, is capturing significant attention in the healthcare sector, particularly within the biotechnology industry. Specializing in innovative..

SI-BONE, Inc. (SIBN) Stock Analysis: Exploring a 34% Potential Upside with Robust Analyst Ratings

SI-BONE, Inc. (NASDAQ: SIBN) stands at the forefront of the healthcare sector, specifically in the medical devices industry. This Santa Clara, California-based company specializes in innovative..

Zymeworks Inc. (ZYME): Analyst Consensus Reveals a Strong 38% Upside Potential for Investors

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, is capturing investor attention with its promising pipeline and robust revenue growth. Specializing in biotherapeutics for cancer, autoimmune,..

InMode Ltd. (INMD) Stock Analysis: Unveiling a 16.26% Potential Upside in the Aesthetic Medical Device Sector

InMode Ltd. (NASDAQ: INMD), a notable player in the healthcare sector focusing on medical devices, has been garnering attention due to its innovative approach in the..

Nuvation Bio Inc. (NUVB) Stock Analysis: 36% Potential Upside with Promising Oncology Pipeline

Nuvation Bio Inc. (NASDAQ: NUVB) is a name gaining traction among biotechnology investors, particularly those focused on oncology. With a market capitalization of $2.84 billion, this..

Spyre Therapeutics (SYRE) Stock Analysis: A Biotech Gem with 55.95% Upside Potential

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is making significant waves in the biotechnology sector, particularly for investors looking to capitalize on its potential growth in the inflammatory..

CorMedix Inc. (CRMD) Stock Analysis: A Potential 61.84% Upside with Innovative Healthcare Solutions

In the ever-evolving world of biotechnology, CorMedix Inc. (NASDAQ: CRMD) is capturing investor attention with its promising growth metrics and a compelling potential upside of 61.84%...

Phibro Animal Health Corporation (PAHC) Stock Analysis: Revenue Growth and Strategic Positioning in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC) has emerged as a noteworthy player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With..

STAAR Surgical Company (STAA) Investor Outlook: Navigating Growth in the Medical Instruments Sector

STAAR Surgical Company (NASDAQ: STAA), a key player in the medical instruments and supplies industry, presents a compelling opportunity for investors keen on the healthcare sector...

CareDx, Inc. (CDNA) Stock Analysis: A Strong Buy with a Promising 12.79% Upside in the Booming Diagnostics Sector

CareDx, Inc. (NASDAQ: CDNA) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $1.05 billion, CareDx..

Paycom Software, Inc. (PAYC) Stock Analysis: Assessing a 28% Potential Upside for Investors

Paycom Software, Inc. (NASDAQ: PAYC), operating within the technology sector, has carved out a significant niche in the software application industry. As a provider of cloud-based..

Alkami Technology, Inc. (ALKT) Stock Analysis: Anticipating a 47% Upside with Robust Revenue Growth

Alkami Technology, Inc. (NASDAQ: ALKT) is positioned at the intersection of digital transformation and financial services, providing cloud-based digital banking solutions across the United States. Headquartered..

Cadence Design Systems, Inc. (CDNS) Stock Analysis: Riding High on a 13.65% Potential Upside

Cadence Design Systems, Inc. (NASDAQ: CDNS) continues to be a standout performer in the technology sector, with its prowess in software applications propelling it to a..

Blackbaud, Inc. (BLKB) Stock Analysis: Exploring a 19.53% Potential Upside

Blackbaud, Inc. (BLKB), a leading provider of cloud software solutions, is capturing the attention of investors with a potential upside of 19.53%, according to recent analyst..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds